Comments
Loading...
Aquestive Therapeutics Rapporto sugli interessi allo scoperto
AQSTNASDAQ
Report sulle vendite allo scoperto
Il short interest su Aquestive Therapeutics Inc (NASDAQ:AQST) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 9.27M a 8.88M. Questo rappresenta il 8.43% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Aquestive Therapeutics Corp (XNAS:AQST) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 3.36M azioni scambiate al giorno, ci vorrebbero 2.64 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
8.88M
Vendite allo scoperto %
8.43%
Giorni di copertura
2.64
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
AQST | Aquestive Therapeutics, Inc. C | 09/15/2025 | 09/24/2025 | 8.43% | 105,368,270 | 8,880,063 | 3,364,972 | 2.64 | |
AQST | Aquestive Therapeutics, Inc. C | 08/29/2025 | 09/10/2025 | 8.80% | 105,368,270 | 9,274,353 | 1,428,924 | 6.49 | |
AQST | Aquestive Therapeutics, Inc. C | 08/15/2025 | 08/26/2025 | 7.98% | 105,368,270 | 8,411,354 | 1,451,410 | 5.8 | |
AQST | Aquestive Therapeutics, Inc. C | 07/31/2025 | 08/11/2025 | 11.28% | 83,722,563 | 9,442,487 | 1,079,132 | 8.75 | |
AQST | Aquestive Therapeutics, Inc. C | 07/15/2025 | 07/24/2025 | 11.96% | 83,722,563 | 10,009,133 | 1,159,487 | 8.63 | |
AQST | Aquestive Therapeutics, Inc. C | 06/30/2025 | 07/10/2025 | 13.36% | 83,722,563 | 11,181,713 | 1,533,379 | 7.29 | |
AQST | Aquestive Therapeutics, Inc. C | 06/13/2025 | 06/25/2025 | 14.34% | 83,722,563 | 12,003,700 | 1,809,121 | 6.64 | |
AQST | Aquestive Therapeutics, Inc. C | 05/30/2025 | 06/10/2025 | 13.30% | 83,722,563 | 11,138,891 | 1,280,001 | 8.7 | |
AQST | Aquestive Therapeutics, Inc. C | 05/15/2025 | 05/27/2025 | 11.75% | 83,722,563 | 9,840,455 | 2,089,368 | 4.71 | |
AQST | Aquestive Therapeutics, Inc. C | 04/30/2025 | 05/09/2025 | 11.22% | 83,832,548 | 9,407,433 | 985,694 | 9.54 | |
AQST | Aquestive Therapeutics, Inc. C | 04/15/2025 | 04/25/2025 | 11.77% | 83,832,548 | 9,870,823 | 1,397,874 | 7.06 | |
AQST | Aquestive Therapeutics, Inc. C | 03/31/2025 | 04/09/2025 | 11.95% | 83,832,548 | 10,021,362 | 1,345,638 | 7.45 | |
AQST | Aquestive Therapeutics, Inc. C | 03/14/2025 | 03/25/2025 | 12.20% | 83,832,548 | 10,228,131 | 1,348,501 | 7.58 | |
AQST | Aquestive Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 11.90% | 83,832,548 | 9,978,681 | 1,654,796 | 6.03 | |
AQST | Aquestive Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 13.10% | 76,139,372 | 9,977,136 | 2,655,726 | 3.76 | |
AQST | Aquestive Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 14.56% | 76,139,372 | 11,086,624 | 1,177,340 | 9.42 | |
AQST | Aquestive Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 15.48% | 76,139,372 | 11,788,486 | 1,745,887 | 6.75 | |
AQST | Aquestive Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 13.77% | 76,139,372 | 10,483,849 | 1,500,236 | 6.99 | |
AQST | Aquestive Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 12.68% | 76,139,372 | 9,653,937 | 1,696,232 | 5.69 | |
AQST | Aquestive Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 13.33% | 76,139,372 | 10,150,852 | 1,255,654 | 8.08 | |
AQST | Aquestive Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 13.09% | 76,139,372 | 9,965,234 | 1,873,758 | 5.32 | |
AQST | Aquestive Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 13.32% | 76,139,372 | 10,143,690 | 1,390,945 | 7.29 | |
AQST | Aquestive Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 14.19% | 76,020,939 | 10,790,957 | 983,521 | 10.97 | |
AQST | Aquestive Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 14.55% | 76,020,939 | 11,063,504 | 1,508,649 | 7.33 | |
AQST | Aquestive Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 14.20% | 76,020,939 | 10,798,108 | 1,052,859 | 10.26 | |
AQST | Aquestive Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 14.21% | 76,020,939 | 10,804,632 | 1,071,816 | 10.08 | |
AQST | Aquestive Therapeutics, Inc. C | 08/15/2024 | 08/26/2024 | 14.19% | 76,020,939 | 10,786,203 | 1,454,632 | 7.42 | |
AQST | Aquestive Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 14.19% | 76,020,939 | 10,788,742 | 1,526,933 | 7.07 | |
AQST | Aquestive Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 13.65% | 75,999,711 | 10,372,107 | 1,097,284 | 9.45 | |
AQST | Aquestive Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 10.04% | 75,999,711 | 7,633,267 | 2,969,918 | 2.57 | |
AQST | Aquestive Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 9.45% | 75,999,711 | 7,181,545 | 916,766 | 7.83 | |
AQST | Aquestive Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 8.82% | 75,999,711 | 6,700,819 | 1,026,034 | 6.53 | |
AQST | Aquestive Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 8.14% | 75,999,711 | 6,183,555 | 1,659,858 | 3.73 | |
AQST | Aquestive Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 6.94% | 75,999,711 | 5,270,839 | 3,108,089 | 1.7 | |
AQST | Aquestive Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 5.27% | 75,999,711 | 4,008,551 | 2,358,908 | 1.7 | |
AQST | Aquestive Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 3.03% | 74,983,871 | 2,273,072 | 3,994,335 | 1 | |
AQST | Aquestive Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 3.09% | 74,983,871 | 2,315,549 | 4,121,781 | 1 | |
AQST | Aquestive Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 3.11% | 58,317,204 | 1,811,878 | 2,528,222 | 1 | |
AQST | Aquestive Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 3.84% | 51,783,286 | 1,988,816 | 637,039 | 3.12 | |
AQST | Aquestive Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 3.35% | 51,783,286 | 1,737,063 | 582,063 | 2.98 | |
AQST | Aquestive Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 3.66% | 51,783,286 | 1,896,934 | 1,035,367 | 1.83 | |
AQST | Aquestive Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 3.96% | 51,783,286 | 2,049,461 | 447,737 | 4.58 | |
AQST | Aquestive Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 4.00% | 51,783,286 | 2,068,952 | 679,911 | 3.04 | |
AQST | Aquestive Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 3.63% | 51,783,286 | 1,877,802 | 440,099 | 4.27 | |
AQST | Aquestive Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 3.71% | 51,783,286 | 1,919,478 | 194,219 | 9.88 | |
AQST | Aquestive Therapeutics, Inc. C | 10/31/2023 | 11/09/2023 | 3.77% | 51,783,286 | 1,954,375 | 186,332 | 10.49 | |
AQST | Aquestive Therapeutics, Inc. C | 10/13/2023 | 10/24/2023 | 3.84% | 51,743,296 | 1,985,439 | 189,711 | 10.47 | |
AQST | Aquestive Therapeutics, Inc. C | 09/29/2023 | 10/10/2023 | 3.93% | 51,743,296 | 2,033,482 | 285,768 | 7.12 |
In cerca di azioni più vendute allo scoperto?